Chemical matrixectomy for ingrown toenails - Is there an evidence basis to guide therapy?

被引：37

作者：

Espensen, EH ^{[1
]}

Nixon, BP ^{[1
]}

Armstrong, DG ^{[1
]}

机构：

[1] So Arizona Vet Affairs Med Ctr, Dept Surg, Podiatry Sect 2 112, Tucson, AZ 85710 USA

来源：

JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION | 2002年 / 92卷 / 05期

关键词：

D O I：

10.7547/87507315-92-5-287

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

Chemical matrixectomy for ingrown toenails is one of the most common surgical procedures performed on the foot. The procedure was first described in 1945 by Otto Boll, who discussed the use of phenol to correct ingrown toenails. In the years that followed, many variations of technique and method have been described. This article reviews the pertinent literature detailing chemical matrixectomies and advocates the use of an evidence basis for care.

引用

页码：287 / 295

页数：9

共 41 条

[1]

*AM COLL FOOT SURG, 1992, INGR TOEN PREF PRACT

[2] Analgesic efficacy of topical butamben picrate [J].

Armstrong, DG ;

Kanat, IO .

JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1995, 85 (12) :738-740

[3]

Boll O., 1945, J NATL ASS CHIR, V35, P8

[4]

Cooper C T Jr, 1965, J Am Podiatry Assoc, V55, P661

[5]

COUGHLIN MJ, 1999, SURG FOOT ANKLE, P1067

[6]

*CTR EV BAS MED, 2001, LEV EV GRAD REC

[7]

DAGNALL JC, 1981, CHIROPODIST, V36, P315

[8] Phenol and alcohol chemical matrixectomy in diabetic versus nondiabetic patients -: A retrospective study [J].

Felton, PM ;

Weaver, TD .

JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1999, 89 (08) :410-412

[9]

Freund P A, 1974, J Am Podiatry Assoc, V64, P421

[10]

FROST L, 1958, J Am Podiatry Assoc, V48, P51

← 1 2 3 4 5 →